Company description: OXB is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Job description: Join us in changing lives. At OXB, our people are at the heart of everything we do. Were on a mission to enable life-changing therapies to reach patients around the worldand were looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful Were currently recruiting for a? Senior Quality Assurance Officer to join our Quality Assurance team. In this role, you will?provide expert QA support for OXB Manufacturing Operations, playing a key part in advancing our mission and making a real difference. Your responsibilities in this role would be: Reviewing and approving deviations, CAPAs and change controls within defined timelines. Supporting manufacturing teams as a QA partner to ensure GMP compliance during production activities. Reviewing batch documentation and support preparation for Qualified Person batch disposition. Participating in investigations, root cause analysis and risk assessments for quality events. Reviewing and approving SOPs, protocols, reports and other GMP documentation. Supporting implementation of new manufacturing processes for incoming client programs. Contributing to continuous improvement initiatives to strengthen quality systems and operational processes. We are looking for: Experience in a GMP-regulated pharmaceutical, biotechnology or similar manufacturing environment. Significant experience managing quality events such as deviations, CAPAs and change controls. Strong understanding of GMP regulations and regulatory expectations (FDA / EMA). Ability to work independently, make sound quality decisions and manage multiple priorities. Strong communication skills and the ability to collaborate closely with manufacturing and technical teams. About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 30 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. Why Join Us? ???Competitive total reward packages ???Wellbeing programmes?that support your mental and physical health ???Career development opportunities?to help you grow and thrive ???Supportive, inclusive, and collaborative culture ???State-of-the-art labs and manufacturing facilities ??A company that lives its values:? Responsible, Responsive, Resilient, Respect We want you to feel inspired every day. AtOXB,werefuture-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork. Ready to Make a Difference? Collaborate. Contribute. Change lives. We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.